Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
The Lancet. Oncology|July 26, 2021
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trialsJaleh Fallah, Lijun Zhang, Anup Amatya, et al.
The Oncologist|November 4, 2020
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate CancerMitchell S Anscher, Elaine Chang, Xin Gao, et al.
JAMA Oncology|November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder CancerAndrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancerLaleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based ChemotherapyGwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Pageof 6